» Articles » PMID: 17366099

Uric Acid As Inducer of Calcium Oxalate Crystal Development

Overview
Publisher Informa Healthcare
Date 2007 Mar 17
PMID 17366099
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This paper deals with the mechanism by which uric acid affects calcium oxalate crystallization and the role of crystallization inhibitors in this process.

Material And Methods: Pure uric acid crystals and fragments of uric acid renal calculi were used to induce calcium oxalate crystal formation and development. These studies were performed in flow systems, using synthetic urine and similar conditions to those found in real renal situations. The type and size of the developed crystals were evaluated by scanning electron microscopy and the amount of calcium oxalate crystallized was quantitated by means of inductively coupled plasma atomic emission spectroscopy.

Results: The presence of uric acid crystals in a flow system provoked calcium oxalate monohydrate (COM) crystallization at a rate of 3.3 microg/h/mg uric acid. When uric acid renal calculi fragments were used, the amount of COM crystallized varied between 0.048 and 0.161 microg/h/mg of renal calculi depending on the porosity of the calculus. At particular concentrations (3.03 microM phytate, 28.75 microM pyrophosphate, 40 mg/l chondroitin sulphate) the crystallization inhibitors assayed produced a maximum decrease of approximately 50% in the amount of COM crystallized on uric acid crystals. Mucin (a glycoprotein) caused only slight effects.

Conclusion: Uric acid crystals can clearly induce the development of COM crystals on them through a heterogeneous nucleation process and some crystallization inhibitors can notably delay such a process.

Citing Articles

Potential association between magnesium depletion score and hyperuricemia in American adults, a cross-sectional study based on NHANES 2003-2018.

Li Z, Wu M, Kong S, Xiao B Prev Med Rep. 2025; 51:103000.

PMID: 40034986 PMC: 11875140. DOI: 10.1016/j.pmedr.2025.103000.


Urinary Risk Profile, Impact of Diet, and Risk of Calcium Oxalate Urolithiasis in Idiopathic Uric Acid Stone Disease.

Siener R, Lohr P, Hesse A Nutrients. 2023; 15(3).

PMID: 36771279 PMC: 9919786. DOI: 10.3390/nu15030572.


Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis.

Grases F, Rodriguez A, Costa-Bauza A PLoS One. 2014; 9(10):e111184.

PMID: 25333633 PMC: 4205022. DOI: 10.1371/journal.pone.0111184.


Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites.

Gao J, Xue J, Xu M, Gui B, Wang F, Ouyang J Int J Nanomedicine. 2014; 9:4399-409.

PMID: 25258530 PMC: 4172125. DOI: 10.2147/IJN.S66000.


A new device for simple and accurate urinary pH testing by the Stone-former patient.

Grases F, Rodriguez A, Berga F, Costa-Bauza A, Prieto R, Burdallo I Springerplus. 2014; 3:209.

PMID: 24839588 PMC: 4022968. DOI: 10.1186/2193-1801-3-209.